Literature DB >> 11851805

Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides.

T Asahara1, K Nomoto, K Shimizu, M Watanuki, R Tanaka.   

Abstract

AIMS: The anti-infectious activity of Bifidobacteria in combination with transgalactosylated oligosaccharides (TOS) against Salmonella enterica serovar Typhimurium LT-2 in an opportunistic antibiotic-induced murine infection model in mice was examined. METHODS AND
RESULTS: B. breve (strain Yakult) with natural resistance to streptomycin sulphate (SM, MIC: > 4 mg ml(-1)), when given daily at a dose of 108 cfu/mouse orally under SM treatment was constantly excreted at 10(10) cfu g(-1) faeces so long as SM was administered, even at 2 weeks after discontinuing administration of B. breve. Explosive intestinal growth and subsequent extra-intestinal translocation of orally infected LT-2 under SM treatment were inhibited by B. breve colonization, and this anti-infectious activity was strengthened by synbiotic administration of TOS with B. breve. Comparison of anti-Salmonella activity among several Bifidobacterium strains with natural resistance to SM revealed that strains such as B. bifidum ATCC 15696 and B. catenulatum ATCC 27539T conferred no activity, even when they reached high population levels similar those of effective strains such as strain Yakult and B. pseudocatenulatum DSM 20439. Both the increase in the concentration of organic acids and the lowered pH in the intestine due to bifidobacterial colonization correlated with the anti-infectious activity. Moreover, the crude cecal extract of B. breve-colonized mice exerted growth-inhibitory activity against LT-2 in vitro, whereas that of the ineffective B. bifidum-colonized cecum showed much lower activity.
CONCLUSIONS: Intestinal colonization by bifidobacteria given exogenously together with TOS during antibiotic treatment prevents the antibiotic-induced disruption of colonization resistance to oral infection with S. enterica serovar Typhimurium, and the metabolic activity needed to produce organic acids and lower the intestinal pH is important in the anti-infectious activity of synbiotics against enteric infection with Salmonella. SIGNIFICANCE AND IMPACT OF THE STUDY: These results indicate that certain bifidobacteria together with prebiotics may be used for the prophylaxis against opportunistic intestinal infections with antibiotic-resistant pathogens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11851805     DOI: 10.1046/j.1365-2672.2001.01461.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  20 in total

1.  Eradication of the commensal intestinal microflora by oral antimicrobials interferes with the host response to lipopolysaccharide.

Authors:  T Umenai; H Hirai; N Shime; T Nakaya; T Asahara; K Nomoto; M Kita; Y Tanaka; J Imanishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-20       Impact factor: 3.267

Review 2.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

3.  The presence and management of contaminants in non-certified, agriculturally sourced food items used as enrichment for laboratory animals.

Authors:  Dale M Cooper
Journal:  Lab Anim (NY)       Date:  2015-02       Impact factor: 12.625

Review 4.  Antibiotics, pediatric dysbiosis, and disease.

Authors:  Pajau Vangay; Tonya Ward; Jeffrey S Gerber; Dan Knights
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

5.  Probiotic Bifidobacterium species: potential beneficial effects in diarrheal disorders. Focus on "Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells".

Authors:  Debolina Ray; Gianfranco Alpini; Shannon Glaser
Journal:  Am J Physiol Cell Physiol       Date:  2014-09-10       Impact factor: 4.249

6.  Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.

Authors:  Christian-U Riedel; Francis Foata; David Philippe; Oskar Adolfsson; Bernhard-J Eikmanns; Stephanie Blum
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  Modulation of rat cecal microbiota by administration of raffinose and encapsulated Bifidobacterium breve.

Authors:  Achmad Dinoto; Akarat Suksomcheep; Satoshi Ishizuka; Hanae Kimura; Satoshi Hanada; Yoichi Kamagata; Kozo Asano; Fusao Tomita; Atsushi Yokota
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

8.  Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium.

Authors:  S J M Ten Bruggencate; I M J Bovee-Oudenhoven; M L G Lettink-Wissink; M B Katan; R Van Der Meer
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

9.  Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies.

Authors:  Mariko Wada; Satoru Nagata; Masahiro Saito; Toshiaki Shimizu; Yuichiro Yamashiro; Takahiro Matsuki; Takashi Asahara; Koji Nomoto
Journal:  Support Care Cancer       Date:  2009-08-14       Impact factor: 3.603

10.  Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report.

Authors:  Kentaro Shimizu; Hiroshi Ogura; Miki Goto; Takashi Asahara; Koji Nomoto; Masami Morotomi; Asako Matsushima; Osamu Tasaki; Kieko Fujita; Hideo Hosotsubo; Yasuyuki Kuwagata; Hiroshi Tanaka; Takeshi Shimazu; Hisashi Sugimoto
Journal:  Dig Dis Sci       Date:  2008-08-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.